These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7729243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Local renin-angiotensin system in human adrenals and aldosteronomas.
    Sarzani R, Fallo F, Dessì-Fulgheri P, Pistorello M, Lanari A, Paci VM, Mantero F, Rappelli A.
    Hypertension; 1992 Jun; 19(6 Pt 2):702-7. PubMed ID: 1592471
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II and the adrenal.
    Giacchetti G, Opocher G, Sarzani R, Rappelli A, Mantero F.
    Clin Exp Pharmacol Physiol Suppl; 1996 Jun; 3():S119-24. PubMed ID: 8993850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Rivière A, Vaidyanathan S, Camisasca RP.
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin system in the adrenal.
    Mulrow PJ.
    Horm Metab Res; 1998 Dec; 30(6-7):346-9. PubMed ID: 9694561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of digoxin on the in vitro secretion of renin and angiotensin II/III immunoreactivity by the human adrenal gland.
    Pistorello M, Cimolato M, Pedini F, Piovan D, Boscaro M, Fallo F.
    Acta Endocrinol (Copenh); 1992 Sep; 127(3):210-4. PubMed ID: 1414145
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
    Oda N, Takeda Y, Zhu A, Usukura M, Yoneda T, Takata H, Mabuchi H.
    Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
    [Abstract] [Full Text] [Related]

  • 17. Secretion of cortisol and aldosterone as a vulnerable target for adrenal endocrine disruption - screening of 30 selected chemicals in the human H295R cell model.
    Ullerås E, Ohlsson A, Oskarsson A.
    J Appl Toxicol; 2008 Nov; 28(8):1045-53. PubMed ID: 18626888
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vascular-adrenal niche--endothelial cell-mediated sensitization of human adrenocortical cells to angiotensin II.
    Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Willenberg HS, Krug AW, Funk RH, Bornstein SR.
    Horm Metab Res; 2006 Jul; 38(7):476-80. PubMed ID: 16933187
    [Abstract] [Full Text] [Related]

  • 20. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK, Williams GH.
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.